Jamjoom Pharmaceuticals Factory Company (4015.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Jamjoom Pharmaceuticals Factory Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 21.56x | 29.88x | 27.53x | 31.87x | 31.99x | 26.39x |
| P/B Ratio | 0.00x | 7.15x | 5.73x | 4.49x | 4.43x | 4.63x |
| P/S Ratio | 6.66x | 8.08x | 7.31x | 5.96x | 7.42x | 6.78x |
| Profitability | ||||||
| Gross Margin | 62.6% | 62.2% | 63.7% | 64.8% | 64.5% | 63.7% |
| Operating Margin | 31.6% | 28.9% | 28.5% | 25.5% | 25.4% | 30.8% |
| Net Margin | 30.9% | 27.0% | 26.6% | 18.7% | 23.2% | 25.7% |
| EBITDA Margin | 31.6% | 31.9% | 31.1% | 23.0% | 28.9% | 35.0% |
| Liquidity | ||||||
| Current Ratio | 0.00x | 5.10x | 5.04x | 5.42x | 5.06x | 3.54x |
| Quick Ratio | 0.00x | 3.76x | 3.74x | 4.38x | 4.08x | 3.00x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.08x |
YoY = year-over-year change. Source: FMP..